Ally Bridge Group

Ally Bridge Group as of March 31, 2021

Portfolio Holdings for Ally Bridge Group

Ally Bridge Group holds 32 positions in its portfolio as reported in the March 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Spdr Ser Tr Put Put Option 20.8 $109M 800k 135.65
Atea Pharmaceuticals (AVIR) 10.7 $56M 904k 61.75
Medavail Holdings Ord 7.8 $41M 2.9M 14.00
Cerevel Therapeutics Hldng I (CERE) 4.6 $24M 1.7M 13.73
Syros Pharmaceuticals 4.5 $24M 3.1M 7.48
Fate Therapeutics (FATE) 4.3 $22M 270k 82.45
Natera (NTRA) 4.2 $22M 218k 101.54
Nuvation Bio Com Cl A (NUVB) 4.0 $21M 2.0M 10.45
Intellia Therapeutics (NTLA) 3.5 $18M 225k 80.25
Repligen Corporation (RGEN) 3.1 $16M 83k 194.41
Cogent Biosciences (COGT) 2.7 $14M 1.6M 8.78
Iovance Biotherapeutics (IOVA) 2.5 $13M 407k 31.66
Miragen Therapeutics (VRDN) 2.2 $11M 681k 16.71
Iteos Therapeutics (ITOS) 2.1 $11M 323k 34.18
Essa Pharma Com New (EPIX) 2.0 $11M 363k 29.05
Oric Pharmaceuticals (ORIC) 1.9 $10M 413k 24.50
Curevac N V (CVAC) 1.9 $10M 110k 91.46
Apellis Pharmaceuticals (APLS) 1.9 $9.9M 230k 42.91
Bolt Biotherapeutics (BOLT) 1.8 $9.5M 288k 32.91
Aptose Biosciences Com New 1.6 $8.4M 1.4M 5.98
Olink Hldg Ab Sponsored Ads (OLK) 1.4 $7.2M 200k 36.00
Arvinas Ord (ARVN) 1.3 $6.9M 104k 66.10
Castle Biosciences (CSTL) 1.3 $6.8M 100k 68.46
Itamar Med Sponsored Ads 1.3 $6.6M 274k 23.95
4d Molecular Therapeutics In (FDMT) 1.2 $6.5M 150k 43.38
Silverback Therapeutics (SPRY) 1.1 $5.6M 129k 43.63
Adicet Bio (ACET) 1.1 $5.6M 425k 13.08
Freeline Therapeutics Hldgs Sponsored Ads 1.0 $5.0M 409k 12.30
Immunovant (IMVT) 0.8 $4.2M 260k 16.04
Orchard Therapeutics Ads 0.8 $4.0M 547k 7.26
Pulmonx Corp (LUNG) 0.5 $2.7M 59k 45.74
Ideaya Biosciences (IDYA) 0.1 $705k 30k 23.50